Cervical Cancer Stages I–IV: What Each Stage Means and How It Is Treated in India

A stage number is not a verdict — it is a description of how far the cancer has progressed. This guide explains what cervical cancer stages I through IV mean, how each is treated, what the survival data shows, and what it costs to receive that treatment in India versus the US or UK.

By Gaf Healthcare Editorial Team

2026-05-10

<!DOCTYPE html> <html lang="en"> <head> <meta charset="UTF-8"> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <title>Cervical Cancer Stages I–IV: What Each Stage Means and How It Is Treated in India</title> <meta name="description" content="Cervical cancer stages I–IV explained simply. Learn what each stage means, how it is treated in India, and what survival rates look like for patients today."> <link rel="preconnect" href="https://fonts.googleapis.com"> <link href="https://fonts.googleapis.com/css2?family=Lora:ital,wght@0,400;0,600;1,400&family=Source+Sans+3:wght@400;500;600&display=swap" rel="stylesheet"> <style> , ::before, *::after { box-sizing: border-box; margin: 0; padding: 0; }

:root { --cream: #F5F2EB; --cream-dark: #EDE9DF; --green-dark: #1B5E3B; --green-mid: #2D7A52; --green-light: #EAF4EE; --green-border: #C2DFCC; --red-accent: #B84040; --red-bg: #FDF2F2; --amber: #B07A15; --amber-bg: #FDF7EC; --amber-border: #E8D5A0; --text-primary: #1A1A18; --text-body: #2E2E2A; --text-muted: #6B6860; --text-green: #1B5E3B; --border-soft: #DDD9CF; }

body { font-family: 'Source Sans 3', sans-serif; background-color: var(--cream); color: var(--text-body); font-size: 18px; line-height: 1.75; -webkit-font-smoothing: antialiased; }

.page-wrap { max-width: 740px; margin: 0 auto; padding: 48px 24px 80px; }

.meta-tag { display: inline-block; font-size: 11px; font-weight: 600; letter-spacing: 0.12em; text-transform: uppercase; color: var(--text-green); background: var(--green-light); border: 1px solid var(--green-border); border-radius: 4px; padding: 3px 10px; margin-bottom: 18px; }

h1 { font-family: 'Lora', Georgia, serif; font-size: clamp(26px, 4vw, 38px); font-weight: 600; line-height: 1.25; color: var(--text-primary); margin-bottom: 18px; letter-spacing: -0.01em; }

.deck { font-size: 19px; line-height: 1.6; color: var(--text-muted); margin-bottom: 28px; border-bottom: 1px solid var(--border-soft); padding-bottom: 28px; }

/ ILLUSTRATION / .illustration-wrap { margin: 8px 0 36px; border-radius: 10px; overflow: hidden; border: 1px solid var(--border-soft); background: var(--cream-dark); } .illustration-wrap svg { display: block; width: 100%; } .img-caption { font-size: 13px; color: var(--text-muted); padding: 10px 16px 12px; border-top: 1px solid var(--border-soft); font-style: italic; line-height: 1.6; }

/ TOC / .toc-box { background: var(--cream-dark); border: 1px solid var(--border-soft); border-radius: 10px; padding: 20px 24px 24px; margin: 0 0 40px; } .toc-label { display: flex; align-items: center; gap: 8px; font-size: 11px; font-weight: 600; letter-spacing: 0.1em; text-transform: uppercase; color: var(--text-muted); margin-bottom: 14px; } .toc-label::before { content: ""; display: inline-block; width: 14px; height: 14px; background: var(--border-soft); border-radius: 2px; } .toc-box ol { list-style: none; padding: 0; display: flex; flex-direction: column; gap: 8px; } .toc-box ol li a { color: var(--text-green); text-decoration: none; font-size: 16px; font-weight: 500; border-bottom: 1px solid transparent; transition: border-color 0.15s; } .toc-box ol li a:hover { border-color: var(--green-mid); }

/ PROSE / .prose h2 { font-family: 'Lora', Georgia, serif; font-size: clamp(20px, 3vw, 26px); font-weight: 600; color: var(--text-primary); margin: 44px 0 6px; padding-bottom: 12px; border-bottom: 1px solid var(--border-soft); letter-spacing: -0.01em; }

.prose p { font-family: 'Lora', Georgia, serif; font-size: 18px; line-height: 1.82; color: var(--text-body); margin-bottom: 16px; max-width: 68ch; } .prose p strong { font-weight: 600; color: var(--text-primary); } .prose p.impact { font-size: 19px; font-style: italic; color: var(--text-muted); border-left: 3px solid var(--green-mid); padding-left: 18px; margin: 24px 0; }

/ QUICK ANSWER / .quick-box { background: var(--green-light); border: 1.5px solid var(--green-border); border-radius: 10px; padding: 20px 24px 22px; margin: 20px 0 24px; } .quick-box .qa-label { font-size: 11px; font-weight: 600; letter-spacing: 0.1em; text-transform: uppercase; color: var(--amber); display: flex; align-items: center; gap: 6px; margin-bottom: 10px; } .quick-box .qa-label::before { content: "⚡"; font-size: 13px; } .quick-box .qa-question { font-family: 'Source Sans 3', sans-serif; font-weight: 600; font-size: 17px; color: var(--text-primary); margin-bottom: 10px; } .quick-box .qa-answer { font-family: 'Source Sans 3', sans-serif; font-size: 16px; line-height: 1.7; color: var(--text-body); } .quick-box .qa-answer strong { color: var(--text-primary); }

/ STAGE CARDS / .stage-card { border: 1px solid var(--border-soft); border-radius: 10px; overflow: hidden; margin: 20px 0 28px; } .stage-card-header { display: flex; align-items: center; gap: 14px; padding: 16px 20px; border-bottom: 1px solid var(--border-soft); } .stage-badge { font-family: 'Source Sans 3', sans-serif; font-size: 13px; font-weight: 600; letter-spacing: 0.06em; padding: 4px 12px; border-radius: 20px; white-space: nowrap; flex-shrink: 0; } .badge-i { background: #EAF4EE; color: #1B5E3B; border: 1px solid #C2DFCC; } .badge-ii { background: #FDF7EC; color: #8A5F10; border: 1px solid #E8D5A0; } .badge-iii { background: #FDF2EC; color: #9A4020; border: 1px solid #E8C8B0; } .badge-iv { background: #FDF2F2; color: #882020; border: 1px solid #E8BABA; }

.stage-card-header h3 { font-family: 'Lora', Georgia, serif; font-size: 18px; font-weight: 600; color: var(--text-primary); line-height: 1.3; } .stage-card-body { padding: 18px 20px 20px; background: #fff; } .stage-card-body p { font-family: 'Source Sans 3', sans-serif; font-size: 16px; line-height: 1.7; color: var(--text-body); margin-bottom: 12px; max-width: none; } .stage-card-body p:last-child { margin-bottom: 0; } .stage-card-body p strong { font-weight: 600; color: var(--text-primary); }

.stage-meta { display: flex; flex-wrap: wrap; gap: 8px; padding: 12px 20px 14px; border-top: 1px solid var(--border-soft); background: var(--cream-dark); } .stage-meta-item { font-family: 'Source Sans 3', sans-serif; font-size: 12px; color: var(--text-muted); line-height: 1.4; } .stage-meta-item strong { color: var(--text-primary); font-weight: 600; } .stage-meta-sep { color: var(--border-soft); }

/ STAT STRIP / .stat-strip { display: grid; grid-template-columns: repeat(auto-fit, minmax(120px, 1fr)); border: 1px solid var(--border-soft); border-radius: 8px; overflow: hidden; margin: 18px 0 24px; } .stat-cell { padding: 14px 16px 16px; border-right: 1px solid var(--border-soft); } .stat-cell:last-child { border-right: none; } .stat-cell .stat-label { font-size: 10px; font-weight: 600; letter-spacing: 0.1em; text-transform: uppercase; color: var(--text-muted); margin-bottom: 5px; } .stat-cell .stat-val { font-size: 24px; font-weight: 600; color: var(--green-mid); font-family: 'Source Sans 3', sans-serif; line-height: 1.1; }

/ COST TABLE / .cost-table { width: 100%; border-collapse: collapse; border: 1px solid var(--border-soft); border-radius: 8px; overflow: hidden; margin: 18px 0 8px; font-size: 14px; } .cost-table thead th { background: var(--cream-dark); padding: 11px 14px; text-align: left; font-size: 10px; font-weight: 600; letter-spacing: 0.07em; text-transform: uppercase; color: var(--text-muted); border-bottom: 1px solid var(--border-soft); } .cost-table thead th.india-head { background: var(--green-light); color: var(--green-dark); } .cost-table tbody td { padding: 11px 14px; border-bottom: 1px solid var(--border-soft); font-family: 'Source Sans 3', sans-serif; color: var(--text-body); line-height: 1.5; vertical-align: top; } .cost-table tbody tr:last-child td { border-bottom: none; } .cost-table tbody td:first-child { font-weight: 600; color: var(--text-primary); width: 35%; } .cost-table .highlight td { background: #FAFAF7; } .cost-table .saving { color: var(--green-mid); font-weight: 600; }

/ CALLOUTS / .callout-green { border-left: 3px solid var(--green-mid); background: var(--green-light); border-radius: 0 8px 8px 0; padding: 16px 20px 18px; margin: 20px 0; } .callout-green .callout-label { font-size: 11px; font-weight: 600; letter-spacing: 0.1em; text-transform: uppercase; color: var(--text-green); margin-bottom: 8px; } .callout-red { border-left: 3px solid var(--red-accent); background: var(--red-bg); border-radius: 0 8px 8px 0; padding: 16px 20px 18px; margin: 20px 0; } .callout-red .callout-label { font-size: 11px; font-weight: 600; letter-spacing: 0.1em; text-transform: uppercase; color: var(--red-accent); margin-bottom: 8px; } .callout-amber { border-left: 3px solid var(--amber); background: var(--amber-bg); border-radius: 0 8px 8px 0; padding: 16px 20px 18px; margin: 20px 0; } .callout-amber .callout-label { font-size: 11px; font-weight: 600; letter-spacing: 0.1em; text-transform: uppercase; color: var(--amber); margin-bottom: 8px; } .callout-green p, .callout-red p, .callout-amber p { font-size: 16px; line-height: 1.7; font-family: 'Source Sans 3', sans-serif; color: var(--text-body); margin: 0; max-width: none; }

.sources-line { font-size: 13px; color: var(--text-muted); margin: 4px 0 24px; font-style: italic; } .source-inline { font-family: 'Source Sans 3', sans-serif; font-size: 12px; color: var(--text-muted); font-style: italic; margin: -10px 0 18px; line-height: 1.5; display: block; }

/ CTAs / .cta-a { background: var(--green-dark); border-radius: 12px; padding: 28px 28px 30px; margin: 32px 0; } .cta-a .cta-h { font-family: 'Source Sans 3', sans-serif; font-size: 18px; font-weight: 600; color: #fff; margin-bottom: 8px; line-height: 1.4; } .cta-a .cta-s { font-family: 'Source Sans 3', sans-serif; font-size: 15px; color: rgba(255,255,255,.78); margin-bottom: 20px; line-height: 1.6; } .btn-white { display: inline-block; background: #fff; color: var(--green-dark); font-family: 'Source Sans 3', sans-serif; font-size: 15px; font-weight: 600; padding: 11px 22px; border-radius: 6px; text-decoration: none; transition: background 0.15s; } .btn-white:hover { background: #e8f4ee; }

.cta-b { border: 1.5px solid var(--green-border); background: #fff; border-radius: 10px; padding: 20px 22px 22px; margin: 24px 0; display: flex; flex-direction: column; gap: 10px; } .cta-b .cta-h { font-family: 'Source Sans 3', sans-serif; font-size: 16px; font-weight: 600; color: var(--text-primary); line-height: 1.4; } .cta-b .cta-s { font-family: 'Source Sans 3', sans-serif; font-size: 14px; color: var(--text-muted); line-height: 1.6; } .btn-green { display: inline-block; background: var(--green-dark); color: #fff; font-family: 'Source Sans 3', sans-serif; font-size: 14px; font-weight: 600; padding: 10px 20px; border-radius: 6px; text-decoration: none; align-self: flex-start; transition: background 0.15s; } .btn-green:hover { background: var(--green-mid); }

.cta-c { display: flex; align-items: flex-start; gap: 14px; background: var(--cream-dark); border: 1px solid var(--border-soft); border-radius: 8px; padding: 16px 20px; margin: 20px 0; text-decoration: none; transition: border-color 0.15s, background 0.15s; } .cta-c:hover { background: var(--green-light); border-color: var(--green-border); } .cta-c .cta-arrow { font-size: 20px; color: var(--green-mid); line-height: 1; flex-shrink: 0; margin-top: 2px; } .cta-c .rl-label { font-size: 15px; color: var(--green-mid); font-weight: 600; margin-bottom: 4px; font-family: 'Source Sans 3', sans-serif; } .cta-c .rl-desc { font-size: 14px; color: var(--text-muted); font-family: 'Source Sans 3', sans-serif; line-height: 1.5; }

@media (max-width: 600px) { .stat-strip { grid-template-columns: 1fr 1fr; } .cost-table { font-size: 13px; } .cost-table thead th, .cost-table tbody td { padding: 9px 10px; } .stage-meta { flex-direction: column; } } </style> </head> <body> <div class="page-wrap">

<span class="meta-tag">Cervical Cancer · Staging</span>

<h1>Cervical Cancer Stages I–IV: What Each Stage Means and How It Is Treated in India</h1>

<p class="deck">A stage number is not a verdict. It is a description of how far the cancer has progressed — and the starting point for every treatment decision ahead. Understanding what your stage actually means is the first step toward choosing the right treatment, and the right place to receive it.</p>

<div class="illustration-wrap"> <svg viewBox="0 0 700 220" xmlns="http://www.w3.org/2000/svg" role="img" aria-label="Anatomical staging diagram showing cervical cancer progression across four stages. The diagram shows a cross-section of the female reproductive anatomy including the uterus, cervix, vagina, and surrounding pelvic structures. Stage I shows a small tumour confined entirely within the cervix, with no spread beyond. Stage II shows the tumour extending beyond the cervix into the upper vagina or parametrial tissue, but not reaching the pelvic wall. Stage III shows the tumour extending to the lower vagina or pelvic wall, with possible involvement of pelvic or para-aortic lymph nodes shown as small circles. Stage IV shows cancer spreading to the bladder or rectum, or to distant organs beyond the pelvis. Each stage is colour-coded from green for Stage I through amber for Stage II, orange for Stage III, to red for Stage IV. Text labels identify key anatomical structures and stage boundaries. India's leading cancer centres treat all four stages using internationally aligned FIGO protocols."> <defs> <linearGradient id="bgCx" x1="0" y1="0" x2="0" y2="1"> <stop offset="0%" stop-color="#EDE9DF"/> <stop offset="100%" stop-color="#E4DFCF"/> </linearGradient> </defs> <rect width="700" height="220" fill="url(#bgCx)"/>

<text x="88" y="22" text-anchor="middle" font-family="'Source Sans 3',sans-serif" font-size="11" font-weight="600" fill="#1B5E3B" letter-spacing="0.06em">STAGE I</text> <text x="263" y="22" text-anchor="middle" font-family="'Source Sans 3',sans-serif" font-size="11" font-weight="600" fill="#8A5F10" letter-spacing="0.06em">STAGE II</text> <text x="438" y="22" text-anchor="middle" font-family="'Source Sans 3',sans-serif" font-size="11" font-weight="600" fill="#9A4020" letter-spacing="0.06em">STAGE III</text> <text x="613" y="22" text-anchor="middle" font-family="'Source Sans 3',sans-serif" font-size="11" font-weight="600" fill="#882020" letter-spacing="0.06em">STAGE IV</text>

<line x1="175" y1="14" x2="175" y2="206" stroke="#DDD9CF" stroke-width="1" stroke-dasharray="4 3"/> <line x1="350" y1="14" x2="350" y2="206" stroke="#DDD9CF" stroke-width="1" stroke-dasharray="4 3"/> <line x1="525" y1="14" x2="525" y2="206" stroke="#DDD9CF" stroke-width="1" stroke-dasharray="4 3"/>

<ellipse cx="88" cy="108" rx="52" ry="72" fill="#F5F2EB" stroke="#C8C4BA" stroke-width="1.5"/> <ellipse cx="88" cy="130" rx="22" ry="28" fill="#F5F2EB" stroke="#C8C4BA" stroke-width="1" stroke-dasharray="3 2"/> <circle cx="88" cy="118" r="10" fill="#2D7A52" opacity="0.75"/> <text x="88" y="178" text-anchor="middle" font-family="'Source Sans 3',sans-serif" font-size="10" fill="#2D7A52" font-weight="600">Confined to cervix</text> <text x="88" y="192" text-anchor="middle" font-family="'Source Sans 3',sans-serif" font-size="10" fill="#6B6860">No spread beyond</text>

<ellipse cx="263" cy="108" rx="52" ry="72" fill="#F5F2EB" stroke="#C8C4BA" stroke-width="1.5"/> <ellipse cx="263" cy="130" rx="22" ry="28" fill="#F5F2EB" stroke="#C8C4BA" stroke-width="1" stroke-dasharray="3 2"/> <circle cx="263" cy="112" r="14" fill="#B07A15" opacity="0.65"/> <ellipse cx="263" cy="140" rx="10" ry="14" fill="#B07A15" opacity="0.35"/> <text x="263" y="178" text-anchor="middle" font-family="'Source Sans 3',sans-serif" font-size="10" fill="#8A5F10" font-weight="600">Beyond cervix</text> <text x="263" y="192" text-anchor="middle" font-family="'Source Sans 3',sans-serif" font-size="10" fill="#6B6860">Not pelvic wall</text>

<ellipse cx="438" cy="108" rx="52" ry="72" fill="#F5F2EB" stroke="#C8C4BA" stroke-width="1.5"/> <ellipse cx="438" cy="130" rx="22" ry="28" fill="#F5F2EB" stroke="#C8C4BA" stroke-width="1" stroke-dasharray="3 2"/> <circle cx="438" cy="110" r="18" fill="#C05030" opacity="0.6"/> <ellipse cx="438" cy="145" rx="14" ry="18" fill="#C05030" opacity="0.4"/>  <circle cx="474" cy="82" r="6" fill="#C05030" opacity="0.6"/> <circle cx="484" cy="96" r="5" fill="#C05030" opacity="0.5"/> <text x="438" y="178" text-anchor="middle" font-family="'Source Sans 3',sans-serif" font-size="10" fill="#9A4020" font-weight="600">Pelvic wall / nodes</text> <text x="438" y="192" text-anchor="middle" font-family="'Source Sans 3',sans-serif" font-size="10" fill="#6B6860">Lower vagina involved</text>

<ellipse cx="613" cy="108" rx="52" ry="72" fill="#F5F2EB" stroke="#C8C4BA" stroke-width="1.5"/> <ellipse cx="613" cy="130" rx="22" ry="28" fill="#F5F2EB" stroke="#C8C4BA" stroke-width="1" stroke-dasharray="3 2"/> <circle cx="613" cy="108" r="20" fill="#A02020" opacity="0.55"/> <ellipse cx="613" cy="148" rx="16" ry="20" fill="#A02020" opacity="0.4"/>  <circle cx="568" cy="55" r="6" fill="#A02020" opacity="0.45"/> <circle cx="655" cy="62" r="5" fill="#A02020" opacity="0.4"/> <line x1="592" y1="94" x2="572" y2="61" stroke="#A02020" stroke-width="1" stroke-dasharray="3 3" opacity="0.5"/> <line x1="632" y1="92" x2="652" y2="66" stroke="#A02020" stroke-width="1" stroke-dasharray="3 3" opacity="0.5"/> <text x="613" y="178" text-anchor="middle" font-family="'Source Sans 3',sans-serif" font-size="10" fill="#882020" font-weight="600">Bladder / rectum</text> <text x="613" y="192" text-anchor="middle" font-family="'Source Sans 3',sans-serif" font-size="10" fill="#6B6860">or distant organs</text>

<rect x="40" y="206" width="620" height="12" rx="0" fill="none"/> <text x="350" y="215" text-anchor="middle" font-family="'Source Sans 3',sans-serif" font-size="10" fill="#2D7A52" font-weight="600">All four stages treated at Apollo · Fortis · Medanta · Tata Memorial using FIGO 2018 and NCCN guidelines</text> </svg> <p class="img-caption">Cervical cancer staging based on the FIGO 2018 classification. Stage I is confined entirely to the cervix. Stage II extends beyond the cervix into the upper vagina or parametrial tissue. Stage III reaches the pelvic wall, lower vagina, or regional lymph nodes. Stage IV involves the bladder, rectum, or distant organs. India's four leading cancer centres treat all stages using internationally aligned protocols — at 80–90% lower cost than the US or UK.</p> </div>

<div class="toc-box"> <div class="toc-label">What's in this guide</div> <ol> <li><a href="#how-staging-works">How cervical cancer staging works</a></li> <li><a href="#stage-i">Stage I — what it means and how it is treated</a></li> <li><a href="#stage-ii">Stage II — what it means and how it is treated</a></li> <li><a href="#stage-iii">Stage III — what it means and how it is treated</a></li> <li><a href="#stage-iv">Stage IV — what is possible</a></li> <li><a href="#cost-india">What treatment costs in India by stage</a></li> <li><a href="#next-steps">What to do when you have your stage</a></li> </ol> </div>

<h2 id="how-staging-works">How cervical cancer staging works</h2>

<p>Cervical cancer is staged using the FIGO system — the International Federation of Gynaecology and Obstetrics classification. Unlike many other cancers, FIGO staging for cervical cancer has historically been clinical rather than surgical, meaning it can be assigned based on examination and imaging rather than requiring surgery first.</p> <span class="source-inline">Sources: FIGO Committee on Gynecologic Oncology, 2018 FIGO Staging Classification for Cervical Cancer · Bhatla N et al., International Journal of Gynaecology and Obstetrics, 2019</span>

<p>The 2018 revision of the FIGO system incorporated lymph node involvement and imaging findings into the staging criteria for the first time. This means staging at a centre with modern imaging — MRI, PET-CT — produces more accurate results than staging by examination alone.</p> <span class="source-inline">Source: Bhatla N et al., "Revised FIGO staging for carcinoma of the cervix uteri," International Journal of Gynaecology and Obstetrics, 2019</span>

<p>This matters enormously for international patients. A patient staged at a facility without MRI capability may receive an inaccurate stage — and therefore an inappropriate treatment plan. India's top cancer centres complete a full staging workup — MRI pelvis, CT chest and abdomen, and PET-CT where indicated — within 48 to 72 hours of arrival.</p>

<div class="quick-box"> <div class="qa-label">Quick answer</div> <div class="qa-question">How is cervical cancer stage determined?</div> <div class="qa-answer">Stage is assigned after pelvic examination, colposcopy or biopsy, and imaging — typically an MRI of the pelvis to assess local extent, and a CT or PET-CT to evaluate lymph node and distant spread. <strong>In India, a full staging workup costs $600–$1,200</strong> — compared to $8,000–$14,000 in the United States. Accurate staging at a high-volume centre is the single most important factor in receiving the right treatment plan.</div> </div>

<p>Cervical cancer has two main histological types — squamous cell carcinoma (about 70% of cases) and adenocarcinoma (about 25%). Understanding your type is part of the <a href="https://gafhealthcare.in/treatments/cervical-cancer-treatment" style="color:var(--green-mid);text-decoration:underline;text-decoration-color:var(--green-border);">full cervical cancer treatment</a> picture. <span class="source-inline">Source: WHO Classification of Tumours, Female Genital Tumours, 5th Edition, 2020 · NCI SEER Cancer Statistics, 2024</span> A small proportion are adenosquamous or rare types. The histological type affects treatment decisions in some situations, particularly for fertility-sparing surgery and some targeted therapy choices.</p>

<p>India's partner hospitals — <a href="https://gafhealthcare.in/hospitals/apollo-hospitals-new-delhi" style="color:var(--green-mid);text-decoration:underline;text-decoration-color:var(--green-border);">Apollo</a>, <a href="https://gafhealthcare.in/hospitals/fortis-memorial-research-institute-gurgaon" style="color:var(--green-mid);text-decoration:underline;text-decoration-color:var(--green-border);">Fortis Memorial</a>, <a href="https://gafhealthcare.in/hospitals/medanta-the-medicity-gurgaon" style="color:var(--green-mid);text-decoration:underline;text-decoration-color:var(--green-border);">Medanta</a>, and <a href="https://gafhealthcare.in/hospitals/tata-memorial-hospital-mumbai" style="color:var(--green-mid);text-decoration:underline;text-decoration-color:var(--green-border);">Tata Memorial</a> — review every new case at a multidisciplinary tumour board that includes gynaecological oncologists, radiation oncologists, radiologists, and pathologists. This collective review is the standard, not a premium option.</p>

<div class="cta-b"> <p class="cta-h">Already have a diagnosis but unsure of your stage?</p> <p class="cta-s">Share your biopsy report and any existing scans with our team. An Indian gynaecological oncologist will review your case and advise on staging and treatment — at no charge, within 24 hours.</p> <a href="https://gafhealthcare.in/contact" class="btn-green">Get Free Staging Review →</a> </div>

<h2 id="stage-i">Stage I — what it means and how it is treated</h2>

<p>Stage I cervical cancer is confined entirely to the cervix. It has not spread to the uterus, vagina, parametrial tissue, or lymph nodes. It is the most treatable stage, with five-year survival rates exceeding 90% for most patients.</p>

<div class="stage-card"> <div class="stage-card-header"> <span class="stage-badge badge-i">Stage I</span> <h3>Tumour confined to the cervix — most treatable stage</h3> </div> <div class="stage-card-body"> <p><strong>Stage IA:</strong> Microscopic invasion only — diagnosed by microscopy, not visible to the naked eye. IA1 involves invasion ≤3 mm depth. IA2 involves invasion 3–5 mm depth. These are treated with less extensive surgery, and fertility-sparing options are often available.</p> <p><strong>Stage IB:</strong> Clinically visible tumour or microscopic tumour larger than IA criteria. IB1 is ≤2 cm, IB2 is 2–4 cm, and IB3 is >4 cm. Larger IB tumours require more aggressive treatment — either radical hysterectomy or concurrent chemoradiation.</p> <p><strong>Treatment in India:</strong> Stage IA1 is typically managed with cone biopsy or simple hysterectomy. Stage IA2 and IB1 are treated with <a href="https://gafhealthcare.in/treatments/cervical-cancer-treatment" style="color:var(--green-mid);text-decoration:underline;text-decoration-color:var(--green-border);">radical hysterectomy</a> — increasingly performed robotically at India's top centres. Stage IB2 and IB3 may be treated with radical hysterectomy or concurrent chemoradiation, depending on tumour characteristics and patient factors. India's gynaecological oncology teams perform fertility-sparing radical trachelectomy for selected young patients with IB1 disease who wish to preserve the ability to have children.</p> <span class="source-inline">Sources: NCCN Clinical Practice Guidelines in Oncology — Cervical Cancer v1.2025 · Plante M et al., "Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery," Journal of Clinical Oncology, 2011</span> <p><strong>Robotic surgery in India:</strong> The da Vinci Xi robotic system — used for radical hysterectomy at Apollo, Fortis, and Medanta — offers shorter hospital stays (1–2 nights vs 5–7 for open surgery), lower blood loss, faster recovery, and equivalent oncological outcomes for appropriate cases.</p> </div> <div class="stage-meta"> <span class="stage-meta-item"><strong>5-year survival:</strong> 80–93%</span> <span class="stage-meta-sep">·</span> <span class="stage-meta-item"><strong>Primary treatment:</strong> Surgery or chemoradiation</span> <span class="stage-meta-sep">·</span> <span class="stage-meta-item"><strong>Hospital stay in India:</strong> 2–5 nights</span> <span class="stage-meta-sep">·</span> <span class="stage-meta-item"><strong>India cost from:</strong> $4,000</span> </div> <div style="padding:6px 20px 10px;background:var(--cream-dark);border-top:1px solid var(--border-soft);"> <span class="source-inline" style="margin:0;">Sources: NCI SEER Cancer Statistics 2024 · FIGO Annual Report on the Results of Treatment in Gynaecological Cancer, 28th Volume, 2021</span> </div> <div class="callout-label">Fertility-sparing surgery in India</div> <p>Radical trachelectomy — removal of the cervix while preserving the uterus — allows selected stage IA2 and IB1 patients to maintain the possibility of future pregnancy. This procedure requires a highly experienced gynaecological oncologist and is available at <a href="https://gafhealthcare.in/hospitals/apollo-hospitals-new-delhi" style="color:var(--green-mid);text-decoration:underline;text-decoration-color:var(--green-border);">Apollo</a> and <a href="https://gafhealthcare.in/hospitals/tata-memorial-hospital-mumbai" style="color:var(--green-mid);text-decoration:underline;text-decoration-color:var(--green-border);">Tata Memorial</a> in India. The cost of radical trachelectomy in India — $5,000–$9,000 — compares with $35,000–$70,000 in the United States. For young women from Africa and South Asia for whom fertility is a priority, this is a clinically and financially meaningful option.</p> </div>

<h2 id="stage-ii">Stage II — what it means and how it is treated</h2>

<p>Stage II cervical cancer has spread beyond the cervix but has not reached the pelvic wall or the lower third of the vagina. It is divided into two substages based on whether the parametrial tissue — the soft tissue adjacent to the cervix — is involved.</p>

<div class="stage-card"> <div class="stage-card-header"> <span class="stage-badge badge-ii">Stage II</span> <h3>Beyond the cervix — curative treatment still the goal</h3> </div> <div class="stage-card-body"> <p><strong>Stage IIA:</strong> Tumour has spread to the upper two-thirds of the vagina but not the parametria. IIA1 is ≤4 cm; IIA2 is >4 cm. Both are treated with concurrent chemoradiation as the standard approach, though surgery is an option for IIA1 at high-volume centres.</p> <p><strong>Stage IIB:</strong> Tumour has spread into the parametrial tissue. Concurrent chemoradiation — external beam radiation combined with weekly cisplatin chemotherapy — is the standard of care. Surgery is not recommended once parametria are involved.</p> <p><strong>Treatment in India:</strong> Stage II is primarily managed with <a href="https://gafhealthcare.in/treatments/cervical-cancer-treatment" style="color:var(--green-mid);text-decoration:underline;text-decoration-color:var(--green-border);">concurrent chemoradiation</a> — external beam radiotherapy (EBRT) delivered five days per week for five to six weeks, combined with weekly intravenous cisplatin, followed by brachytherapy (internal radiation). India's top centres use image-guided adaptive brachytherapy — a modern technique that significantly reduces bladder and rectal toxicity while maintaining tumour coverage. This is the same technique used at leading European cancer centres and is available at Apollo, Tata Memorial, and Medanta.</p> <p><strong>Brachytherapy in India:</strong> High-dose-rate (HDR) brachytherapy — considered essential for curative treatment of stage II–III cervical cancer — is available at all four GAF Healthcare partner hospitals. The full brachytherapy course in India costs $2,000–$4,500, compared to $15,000–$35,000 in the United States.</p> <span class="source-inline" style="padding:0 0 8px 0;display:block;">Sources: Pötter R et al., "MRI-guided adaptive brachytherapy in locally advanced cervical cancer," Radiotherapy and Oncology, 2011 · GEC-ESTRO Working Group Guidelines for Image-based Brachytherapy in Cervical Cancer · Tata Memorial Hospital Brachytherapy Programme Annual Report 2023</span> </div> <div class="stage-meta"> <span class="stage-meta-item"><strong>5-year survival:</strong> 58–75%</span> <span class="stage-meta-sep">·</span> <span class="stage-meta-item"><strong>Primary treatment:</strong> Concurrent chemoradiation + brachytherapy</span> <span class="stage-meta-sep">·</span> <span class="stage-meta-item"><strong>India cost from:</strong> $6,000</span> </div> <div style="padding:6px 20px 10px;background:var(--cream-dark);border-top:1px solid var(--border-soft);"> <span class="source-inline" style="margin:0;">Sources: NCI SEER Cancer Statistics 2024 · FIGO Annual Report, 28th Volume, 2021 · Rose PG et al., "Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer," NEJM, 1999</span> </div>

<div class="cta-b"> <p class="cta-h">Diagnosed with stage II cervical cancer and exploring your options?</p> <p class="cta-s">Our India-based gynaecological oncology coordinators can review your case, confirm your treatment pathway, and give you honest cost figures within 24 hours — at no charge.</p> <a href="https://gafhealthcare.in/contact" class="btn-green">Talk to Our Medical Team →</a> </div>

<h2 id="stage-iii">Stage III — what it means and how it is treated</h2>

<p>Stage III cervical cancer has spread to the pelvic wall, the lower third of the vagina, causes hydronephrosis (kidney obstruction due to ureteral compression), or has spread to pelvic or para-aortic lymph nodes. The 2018 FIGO revision added lymph node involvement as a staging criterion, making imaging essential for accurate staging.</p>

<div class="stage-card"> <div class="stage-card-header"> <span class="stage-badge badge-iii">Stage III</span> <h3>Locally advanced — intensive treatment, cure still possible</h3> </div> <div class="stage-card-body"> <p><strong>Stage IIIA:</strong> Tumour involves the lower third of the vagina but has not reached the pelvic wall.</p> <p><strong>Stage IIIB:</strong> Tumour extends to the pelvic wall and/or causes hydronephrosis or non-functioning kidney.</p> <p><strong>Stage IIIC:</strong> Pelvic (IIIC1) or para-aortic (IIIC2) lymph node involvement, regardless of tumour size. This substage was added in the 2018 FIGO revision — meaning some patients previously staged as II are now correctly staged as IIIC once lymph node imaging is done.</p> <p><strong>Treatment in India:</strong> Stage III is treated with concurrent chemoradiation — extended-field radiation covering both the pelvis and para-aortic nodes in IIIC2 disease — combined with weekly cisplatin, followed by brachytherapy. The addition of pembrolizumab (immunotherapy) to concurrent chemoradiation in persistent, recurrent, or metastatic cervical cancer has shown benefit in the KEYNOTE-826 trial, and is being incorporated into first-line treatment protocols at India's leading centres for eligible patients.</p> <span class="source-inline" style="padding:0 0 8px 0;display:block;">Sources: Colombo N et al., "Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer," NEJM 2022 (KEYNOTE-826) · NCCN Clinical Practice Guidelines — Cervical Cancer v1.2025</span> <p><strong>Why tumour board review matters at this stage:</strong> Stage III treatment planning is complex. The radiation field must cover a large volume while protecting the bladder, rectum, and bowel. The decision about para-aortic node coverage, the brachytherapy technique, and whether to add immunotherapy all require collective oncology review. India's partner hospitals hold weekly tumour boards specifically for this patient group.</p> </div> <div class="stage-meta"> <span class="stage-meta-item"><strong>5-year survival:</strong> 32–57% (varies by substage)</span> <span class="stage-meta-sep">·</span> <span class="stage-meta-item"><strong>Treatment:</strong> Chemoradiation + brachytherapy ± immunotherapy</span> <span class="stage-meta-sep">·</span> <span class="stage-meta-item"><strong>India cost from:</strong> $8,000</span> </div> <div style="padding:6px 20px 10px;background:var(--cream-dark);border-top:1px solid var(--border-soft);"> <span class="source-inline" style="margin:0;">Sources: NCI SEER Cancer Statistics 2024 · FIGO Annual Report, 28th Volume, 2021 · Monk BJ et al., "Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma," JCO, 2009</span> </div>

<p class="impact">"Stage III is where the quality of the radiation team — their experience with brachytherapy, their imaging capability, their commitment to protecting surrounding organs — makes the difference between cure and significant long-term toxicity."</p>

<div class="callout-red"> <div class="callout-label">The brachytherapy gap in sub-Saharan Africa and South Asia</div> <p>High-dose-rate brachytherapy — essential for curative treatment of stage II–III cervical cancer — is unavailable in most public hospitals across sub-Saharan Africa. The WHO estimates that less than 30% of African cancer patients who need radiation therapy can access it. A woman in <a href="https://gafhealthcare.in/nigeria/treatment-in-india" style="color:var(--red-accent);text-decoration:underline;text-decoration-color:#E8BABA;">Nigeria</a>, <a href="https://gafhealthcare.in/ghana/treatment-in-india" style="color:var(--red-accent);text-decoration:underline;text-decoration-color:#E8BABA;">Ghana</a>, <a href="https://gafhealthcare.in/kenya/treatment-in-india" style="color:var(--red-accent);text-decoration:underline;text-decoration-color:#E8BABA;">Kenya</a>, or <a href="https://gafhealthcare.in/zambia/treatment-in-india" style="color:var(--red-accent);text-decoration:underline;text-decoration-color:#E8BABA;">Zambia</a> diagnosed with stage II or III cervical cancer is not choosing between good and better treatment. She is frequently choosing between travelling for curative treatment and receiving inadequate or no treatment locally. India's cancer centres offer the full brachytherapy-inclusive protocol at a cost that is within reach of most families.</p> </div> <span class="source-inline">Sources: WHO, "Radiation Therapy for Cancer," Global Access to Cancer Care Report, 2021 · Atun R et al., "Expanding global access to radiotherapy," The Lancet Oncology, 2015 · IAEA Division of Human Health, Cancer Control Programme, 2023</span>

<a href="https://gafhealthcare.in/treatments/cervical-cancer-treatment" style="text-decoration:none;" class="cta-c"> <div class="cta-arrow">→</div> <div> <div class="rl-label">Full Cervical Cancer Treatment Guide — GAF Healthcare</div> <div class="rl-desc">All treatment pathways explained: surgery, chemoradiation, brachytherapy, immunotherapy, costs, and how to arrange care in India from your country.</div> </div> </a>

<h2 id="stage-iv">Stage IV — what is possible</h2>

<p>Stage IV cervical cancer has spread to the bladder or rectum (Stage IVA) or to distant organs such as the lungs, liver, or bones (Stage IVB). It is the most advanced stage and is generally not curable — but treatment can extend survival, manage symptoms, and preserve quality of life for a meaningful period.</p>

<div class="stage-card"> <div class="stage-card-header"> <span class="stage-badge badge-iv">Stage IV</span> <h3>Advanced disease — control and quality of life are the goals</h3> </div> <div class="stage-card-body"> <p><strong>Stage IVA:</strong> Cancer has spread to the mucosa of the bladder or rectum. Pelvic exenteration — extensive surgery removing the bladder, rectum, and surrounding structures — may be considered in very selected patients where the disease is confined to the pelvis and the patient is fit for major surgery. This is a complex procedure available at Tata Memorial Hospital in Mumbai for appropriate cases.</p> <p><strong>Stage IVB:</strong> Distant metastases to lungs, liver, bones, or distant lymph nodes. Treatment is systemic — chemotherapy with or without targeted therapy and immunotherapy. The standard first-line regimen is platinum-based chemotherapy (cisplatin or carboplatin with paclitaxel) with or without bevacizumab. The addition of pembrolizumab in PD-L1-positive tumours, established by the KEYNOTE-826 trial, has significantly improved progression-free and overall survival in this group.</p> <span class="source-inline" style="padding:0 0 8px 0;display:block;">Sources: Colombo N et al., KEYNOTE-826 — Pembrolizumab + chemotherapy vs placebo + chemotherapy in cervical cancer, NEJM 2022 · Tewari KS et al., "Bevacizumab for advanced cervical cancer" (GOG-240 trial), NEJM, 2014</span> <p><strong>Available in India:</strong> Bevacizumab biosimilars — clinically equivalent to the original Avastin but manufactured at Indian costs — are available at <a href="https://gafhealthcare.in/hospitals/apollo-hospitals-new-delhi" style="color:var(--green-mid);text-decoration:underline;text-decoration-color:var(--green-border);">Apollo</a>, <a href="https://gafhealthcare.in/hospitals/fortis-memorial-research-institute-gurgaon" style="color:var(--green-mid);text-decoration:underline;text-decoration-color:var(--green-border);">Fortis</a>, <a href="https://gafhealthcare.in/hospitals/medanta-the-medicity-gurgaon" style="color:var(--green-mid);text-decoration:underline;text-decoration-color:var(--green-border);">Medanta</a>, and <a href="https://gafhealthcare.in/hospitals/tata-memorial-hospital-mumbai" style="color:var(--green-mid);text-decoration:underline;text-decoration-color:var(--green-border);">Tata Memorial</a> at $200–$500 per cycle, compared to $4,000–$8,000 per cycle in the United States. Pembrolizumab is available at $1,200–$2,200 per cycle, compared to $10,000–$14,000 in the US. For stage IVB patients, India is often the only accessible source of these drugs.</p> <p><strong>Palliative care:</strong> India's leading cancer centres have dedicated palliative care teams that manage pain, bleeding, and other symptoms of advanced cervical cancer. Palliative radiation — to control local tumour-related bleeding or pain — is also available and can significantly improve quality of life even when cure is not the goal.</p> </div> <div class="stage-meta"> <span class="stage-meta-item"><strong>5-year survival:</strong> ~17% (stage IVB), higher for IVA with exenteration</span> <span class="stage-meta-sep">·</span> <span class="stage-meta-item"><strong>Treatment:</strong> Systemic chemotherapy ± bevacizumab ± pembrolizumab</span> <span class="stage-meta-sep">·</span> <span class="stage-meta-item"><strong>India monthly cost from:</strong> $600</span> </div> <div style="padding:6px 20px 10px;background:var(--cream-dark);border-top:1px solid var(--border-soft);"> <span class="source-inline" style="margin:0;">Sources: NCI SEER Cancer Statistics 2024 · FIGO Annual Report, 28th Volume, 2021 · Tewari KS et al., GOG-240 trial, NEJM 2014</span> </div>

<div class="cta-a"> <p class="cta-h">Dealing with advanced cervical cancer and unsure what is available?</p> <p class="cta-s">Share your diagnosis details and current treatment history. Our team will outline what therapies are available in India, what they cost, and whether transitioning care makes sense for your situation — at no charge, within 24 hours.</p> <a href="https://gafhealthcare.in/contact" class="btn-white">Get a Free Second Opinion →</a> </div>

<h2 id="cost-india">What cervical cancer treatment costs in India by stage</h2>

<p>The cost advantage India offers for cervical cancer treatment is consistent across all stages — but it is most dramatic for the drug-intensive and radiation-intensive protocols used in stage II, III, and IV disease.</p>

<table class="cost-table"> <thead> <tr> <th>Stage & treatment</th> <th>USA</th> <th>UK</th> <th class="india-head">India ✦</th> </tr> </thead> <tbody> <tr> <td>Stage IA — cone biopsy or simple hysterectomy</td> <td>$15,000–$35,000</td> <td>£8,000–£18,000</td> <td class="saving">$2,000–$4,500</td> </tr> <tr class="highlight"> <td>Stage IB — radical hysterectomy (robotic)</td> <td>$40,000–$80,000</td> <td>£18,000–£40,000</td> <td class="saving">$5,000–$10,000</td> </tr> <tr> <td>Stage IB–IIA — radical trachelectomy (fertility-sparing)</td> <td>$35,000–$70,000</td> <td>£16,000–£35,000</td> <td class="saving">$5,000–$9,000</td> </tr> <tr class="highlight"> <td>Stage IIB–III — full chemoradiation + brachytherapy course</td> <td>$80,000–$180,000</td> <td>£35,000–£80,000</td> <td class="saving">$8,000–$18,000</td> </tr> <tr> <td>Brachytherapy course alone (HDR, full)</td> <td>$15,000–$35,000</td> <td>£8,000–£18,000</td> <td class="saving">$2,000–$4,500</td> </tr> <tr class="highlight"> <td>Stage IVB — cisplatin + paclitaxel + bevacizumab (per cycle)</td> <td>$8,000–$15,000</td> <td>£4,000–£8,000</td> <td class="saving">$600–$1,400</td> </tr> <tr> <td>Pembrolizumab (per cycle)</td> <td>$10,000–$14,000</td> <td>£5,000–£8,000</td> <td class="saving">$1,200–$2,200</td> </tr> <tr class="highlight"> <td>Full staging workup (MRI pelvis + CT + PET-CT)</td> <td>$8,000–$14,000</td> <td>£4,000–£7,000</td> <td class="saving">$600–$1,200</td> </tr> </tbody> </table> <p class="sources-line">✦ India figures from GAF Healthcare hospital network, 2025–2026. US figures from FAIR Health. UK figures from NHS reference costs and private sector data.</p>

<div class="stat-strip"> <div class="stat-cell"><div class="stat-label">Average saving vs USA</div><div class="stat-val">~88%</div></div> <div class="stat-cell"><div class="stat-label">Average saving vs UK</div><div class="stat-val">~80%</div></div> <div class="stat-cell"><div class="stat-label">Bevacizumab biosimilar India</div><div class="stat-val">~$300</div></div> <div class="stat-cell"><div class="stat-label">India medical visa time</div><div class="stat-val">5–10 days</div></div> </div>

<div class="callout-amber"> <div class="callout-label">Why India's radiation cost advantage is particularly significant for cervical cancer</div> <p>Cervical cancer is one of the most radiation-sensitive cancers in oncology. Concurrent chemoradiation followed by brachytherapy is curative for many stage II and III patients — but only when delivered correctly, with image guidance and modern brachytherapy technique. In the US, this treatment course costs $80,000–$180,000. In India, the same course — delivered on the same equipment, by teams who trained at the same international institutions, following the same GEC-ESTRO guidelines — costs $8,000–$18,000. The equipment and the technique are the same. The economics are not.</p> </div> <span class="source-inline">Sources: Pötter R et al., GEC-ESTRO recommendations for image-based intracavitary brachytherapy — Radiotherapy and Oncology, 2006 · FAIR Health US Healthcare Cost Database, 2024 · GAF Healthcare hospital network pricing data, 2025–2026</span>

<h2 id="next-steps">What to do when you have your stage</h2>

<p>A stage number without a treatment plan is just a number. Here is a practical sequence for patients who have their diagnosis and are considering treatment in India.</p>

<p><strong>Confirm your staging is complete.</strong> A full staging workup for cervical cancer requires pelvic MRI, CT of the chest and abdomen, and — for stage IIB and above — a PET-CT to evaluate lymph node involvement. If any of these are missing, your stage may not be accurate and your treatment plan may be wrong.</p>

<p><strong>Understand your histological type.</strong> Squamous cell carcinoma and adenocarcinoma respond similarly to radiation, but differ in some aspects of surgical management and targeted therapy eligibility. Ask your oncologist or pathologist which type you have.</p>

<p><strong>Ask about brachytherapy availability.</strong> If you are stage IIB or above and being treated locally, confirm that your centre has HDR brachytherapy capability. External beam radiation alone — without brachytherapy — is significantly less effective for cervical cancer and should not be accepted as a substitute for the complete treatment.</p> <span class="source-inline">Source: Han K et al., "Trends in the utilisation of brachytherapy in cervical cancer in the United States," International Journal of Radiation Oncology Biology Physics, 2013 · Gill BS et al., "National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer," IJROBP, 2014</span>

<p><strong>Get a second opinion before committing to a treatment plan.</strong> This is standard practice at every major cancer centre. In India, second opinion consultations are done remotely — you send your reports, an oncologist reviews them, and you receive a written clinical opinion covering your full <a href="https://gafhealthcare.in/treatments/cervical-cancer-treatment" style="color:var(--green-mid);text-decoration:underline;text-decoration-color:var(--green-border);">cervical cancer treatment options</a>. GAF Healthcare arranges this at no cost.</p>

<p><strong>Plan realistically for the treatment timeline.</strong> Concurrent chemoradiation for cervical cancer runs five to six weeks of daily radiation plus weekly cisplatin, followed by brachytherapy sessions over one to two weeks. The full treatment course requires approximately seven to eight weeks in India. GAF Healthcare coordinates accommodation near the hospital for the full treatment period.</p>

<div class="callout-green"> <div class="callout-label">For patients from Nigeria, Kenya, Ghana, Tanzania, Zambia, and Bangladesh</div> <p>GAF Healthcare has country-specific guidance and coordination experience for patients from all six countries — including visa application support, recommended travel routes, accommodation options near each hospital, and coordinators familiar with patients from your region. If you are from one of these countries, mention it when you contact us. We will route your case to the coordinator with the most relevant experience and fastest response time for your nationality.</p> </div>

<div class="cta-a"> <p class="cta-h">Ready to explore cervical cancer treatment in India for your stage?</p> <p class="cta-s">Share your diagnosis, staging reports, and any existing scans. Our medical team will review everything, recommend the right hospital and oncologist for your stage, and give you honest cost figures — at no charge, within 24 hours.</p> <a href="https://gafhealthcare.in/contact" class="btn-white">Start My Free Consultation →</a> </div>

<a href="https://gafhealthcare.in/treatments/cervical-cancer-treatment" style="text-decoration:none;" class="cta-c"> <div class="cta-arrow">→</div> <div> <div class="rl-label">Full Cervical Cancer Treatment Guide — GAF Healthcare</div> <div class="rl-desc">Surgery, chemoradiation, brachytherapy, immunotherapy, recovery timelines, and costs — everything international patients need to plan cervical cancer treatment in India.</div> </div> </a>

</div> </div> </body> </html>